A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 product (Q40123481)
Jump to navigation
Jump to search
scientific article published on 5 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 product |
scientific article published on 5 June 2007 |
Statements
A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production (English)
Hiroo Hasegawa
Yasuaki Yamada
Kanki Komiyama
Masahiko Hayashi
Toshiaki Sunazuka
Takeshi Izuhara
Kazuyuki Sugahara
Kazuto Tsuruda
Masato Masuda
Nobuyuki Takasu
Kunihiro Tsukasaki
Masao Tomonaga
Shimeru Kamihira